What relief options may help?
Chemotherapy-induced peripheral neuropathy (CIPN) is damage to nerves outside the brain and spinal cord caused by some cancer treatments. The pain, numbness, or tingling it can bring is real and deserves attention. Care can aim to ease symptoms, protect daily function, and reduce injury risk, but results vary and no treatment can reliably reverse nerve damage.
Tell the oncology team promptly about new or worsening symptoms, since cancer-treatment decisions must be made with them. Symptom care may include individualized medication management, rehabilitation, safety steps, and coordination between clinicians. Dr. Rebecca Kerr, dual board-certified in Pain Medicine and Anesthesiology and UCLA-trained, has practiced pain management exclusively for more than 25 years.
What can chemotherapy-related neuropathy feel like?
Chemotherapy-related neuropathy often causes tingling, numbness, burning or sharp pain in the hands and feet. Some people also notice unusual sensitivity to touch or temperature, or weakness. Symptoms can affect sleep and make walking, balance, coordination, or small tasks such as fastening clothing more difficult.
Symptoms may begin during chemotherapy or after treatment ends, and can last for months or years. Sometimes they worsen for a while after chemotherapy has ended, a pattern called “coasting.” This change alone does not mean cancer has returned, but it is worth discussing with the care team. Johns Hopkins Medicine explains the symptoms and course of chemotherapy-induced peripheral neuropathy.
Tell your oncology team promptly about new or worsening numbness, pain, weakness, or changes in balance or hand function. Do not change or stop chemotherapy on your own; decisions about cancer treatment belong with you and your oncology team.
How is the cause and severity assessed?
Assessment usually starts with a review of your cancer-treatment history, symptoms, and how they affect daily activities. A clinician will also examine sensation, strength, reflexes, and coordination to understand which nerves may be involved.
Chemotherapy-related neuropathy is not the only possible cause of numbness, pain, or weakness. Depending on your symptoms, clinicians may order blood tests or nerve tests, such as nerve conduction studies (which measure how fast electrical signals travel through nerves) or electromyography (which records electrical activity in muscles), and sometimes a skin biopsy to look for small-fiber nerve damage. Johns Hopkins Medicine describes these as possible parts of a tailored evaluation.
If symptoms persist, change, or do not fit the expected pattern, a fresh assessment can help identify other causes rather than assuming they are all due to chemotherapy. Decisions about cancer treatment belong with you and your oncology team; do not change or stop treatment on your own.
Dr. Rebecca Kerr, a UCLA-trained, dual board-certified physician in Pain Medicine and Anesthesiology with more than 25 years practicing pain management exclusively, emphasizes patient education and coordination with other clinicians. At California Pain Institute, that may include working with your oncology team while considering pain care for neuropathy. Dr. Kerr sees patients at her offices in Torrance (South Bay) and Los Angeles near LAX. Learn more about Dr. Kerr.
Seek emergency care for sudden weakness or loss of bladder or bowel control. For ongoing or changing symptoms, request an appointment with Dr. Rebecca Kerr, a dual board-certified pain specialist with more than 25 years of experience.
What treatments may ease painful symptoms?
Care for chemotherapy-induced peripheral neuropathy is individualized. Treatment aims to ease pain and preserve daily function, not promise that damaged nerves will heal. Any change to chemotherapy, including a dose reduction, delay, or stop, must be decided with the oncology team.
Duloxetine, a non-opioid medicine, may help some people with painful CIPN, though it may not help everyone or ease numbness to the same degree. Gabapentin or pregabalin may also be considered, but evidence for these medicines in CIPN is less consistent.
Discuss possible benefits, side effects, risks, and interactions with your physician before making medication decisions. Opioids may have a role for some people with severe pain; treatment should be individualized and should not stigmatize anyone who uses them.
Dr. Rebecca Kerr, a UCLA-trained physician who is dual board-certified in Pain Medicine and Anesthesiology and has practiced pain management exclusively for more than 25 years, considers non-opiate, non-addicting options first when appropriate. Medication management is coordinated with the oncology team and other clinicians.
At California Pain Institute, assessment and medication management may be paired with ultrasound- or X-ray-guided spinal, nerve, joint, soft-tissue, or trigger point injections when appropriate. These procedures do not repair chemotherapy-related nerve damage, and an injection is not suitable for everyone.
Experimental approaches, including research into AEG-1, are not established treatments available for CIPN. Dr. Kerr’s care includes explaining what an option may address, its limits, and how it fits with ongoing cancer care.
Learn more about Dr. Rebecca Kerr and the practice’s approach to neuropathy.
How can daily function and safety be supported?
Physical and occupational therapy can help address weakness, walking, balance, hand function, and daily tasks. A physical therapist can tailor exercises and fall-prevention strategies, while an occupational therapist can suggest safer ways to manage dressing, cooking, and other activities. These referrals can be coordinated with your other clinicians, as part of chemotherapy-induced neuropathy care.
At home, use handrails, clear loose rugs and clutter, and wear supportive shoes that fit well. Check your hands and feet for cuts or sores, use gloves around hot objects, and test bathwater carefully when sensation is reduced.
Choose activity that feels manageable, and ask your clinician or therapist what is suitable for your health and balance. Rest when needed rather than pushing through fatigue or pain.
Neuropathy can affect sleep and emotional well-being. Counseling, support groups, mindfulness, relaxation, and regular communication with your care team may offer support. Ask your physician before taking vitamins or supplements, since they may interact with cancer treatment or carry risks.
At California Pain Institute, Dr. Rebecca Kerr, dual board-certified in Pain Medicine and Anesthesiology, coordinates care with other clinicians and can discuss function and safety. She is UCLA-trained and has practiced pain management exclusively for more than 25 years. The practice serves patients in Torrance in the South Bay and in Los Angeles near LAX. Learn more about Dr. Kerr or request an appointment with Dr. Kerr. Call Torrance at (310) 504-0632 or Los Angeles at (310) 642-7900.
What should patients know about relief options?
Relief for chemotherapy-related nerve pain depends on the symptoms, their effect on daily life, and the person’s overall care plan. Treatment may ease pain and support function, but it cannot reliably reverse nerve damage. Keep the oncology team informed, especially if symptoms change.
Frequently asked questions
Can chemotherapy cause peripheral neuropathy, and what symptoms can it cause? Yes. Some chemotherapy medicines can damage peripheral nerves, causing numbness, tingling, burning or sharp pain, sensitivity, weakness, or balance problems, often in the hands and feet. Symptoms may start during treatment or later. Report changes to your cancer care team, and do not change treatment without medical guidance. Johns Hopkins Medicine explains chemotherapy-induced peripheral neuropathy.
How is chemotherapy-induced peripheral neuropathy treated? Care is tailored to symptoms and daily needs. Any cancer-treatment changes belong with the oncology team; symptom care may include medication management and rehabilitation support. Dr. Rebecca Kerr, dual board-certified in Pain Medicine and Anesthesiology, UCLA-trained, and practicing pain management exclusively for more than 25 years, emphasizes non-opiate, non-addicting options when appropriate and coordinates care with other clinicians. Learn about Dr. Kerr.
Is duloxetine an option for chemotherapy-induced neuropathy? It may be considered for painful neuropathy, but suitability depends on symptoms, medical history, cancer treatment, and other medicines. Ask a physician about possible benefits, side effects, and interactions; do not change medication without medical guidance.
Does chemotherapy-induced neuropathy go away, or can it worsen after treatment? Symptoms may improve, persist, or worsen temporarily after chemotherapy ends; the course varies. Contact a clinician about ongoing or changing symptoms. Sudden weakness or loss of bladder or bowel control needs emergency care.
Can chemotherapy-induced neuropathy be prevented, or can vitamins and natural remedies help? No medication or intervention has been proven to reliably prevent it in routine practice. Supplements can carry risks or interact with cancer treatment, so ask a physician before using them.
Request an appointment with Dr. Kerr. Call Torrance (South Bay) at (310) 504-0632 or Los Angeles near LAX at (310) 642-7900.
Coordinated care can support daily life
Persistent chemotherapy-related nerve pain is real and deserves individualized attention. A pain specialist can coordinate with your oncology team to address symptoms and daily function, while decisions about chemotherapy remain with your oncologist. Discuss medication choices with your physician; no single approach can promise that nerve damage will resolve.
Request an appointment with Dr. Kerr. Call Torrance at (310) 504-0632 or Los Angeles at (310) 642-7900 to discuss an evaluation and coordinated care.
